Skip to content

FURIEX PHARMACEUTICALS, INC.

CIK 0001484478

← back to feed
Revenue (TTM)
$64.29M
−15.5% YoY Q1 Apr 2014
Net Income (TTM)
−$36.22M
+25.1% YoY Q1 Apr 2014
EPS Diluted (TTM)
−$0.63
+25.9% YoY Q1 Apr 2014
Gross Margin
—
Q1 Apr 2014
Operating Margin
-48.6%
Q1 Apr 2014
Net Margin
-56.3%
Q1 Apr 2014
Free Cash Flow (TTM)
−$25.71M
Q1 Apr 2014
Cash
$22.9M
Q1 Apr 2014
Total Debt
$42M
Q1 Apr 2014
Shares Outstanding
10.81M sh
Q1 Apr 2014

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings